Trial ID or NCT#

NCT02687035

Status

RECRUITING

Purpose

The purpose of this trial is to determine the safety and effectiveness of the Edwards Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.

Official Title

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)

Eligibility Criteria

Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Rajesh Dash, MD, PhD, Medical & Scientific Director, SSATHI
Cardiologist
Assistant Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
D. Craig Miller, M.D.
Cardiovascular surgeon
Thelma and Henry Doelger Professor in Cardiovascular Surgery

Contact us to find out if this trial is right for you.

CONTACT

Leigh Trautman, RN
(650) 725-3931